ALHC · Alignment Healthcare, Inc. · Executive Compensation
$6.72
-0.90 (-11.81%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.41B
Shares
209.27M
Volume · Nov 18
6.79M
Avg daily vol (3M)
8.05M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Hakan Kardes | Chief Experience Officer | Resigned | 2025-04-15 |
| Dawn Maroney | President | Appointed | 2025-01-13 |
|
Thomas Carella
“The resignations of Mr. Margolis and Mr. Carella were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
|
member of the Board | Resigned | 2024-08-16 |
|
Jeffrey Margolis
“The resignations of Mr. Margolis and Mr. Carella were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
|
member of the Board | Resigned | 2024-08-16 |
| Joseph Konowiecki | executive role leading strategic network and business development | Terminated | 2023-12-29 |
| Hyong (Ken) Kim, M.D. | Chief Medical Officer | Appointed | 2023-09-06 |
| Dr. Dinesh Kumar | Chief Medical and Operating Officer | Terminated | 2023-08-15 |
| Richard Cross | Senior Vice President, General Counsel and Corporate Secretary | Retired | 2023-07-14 |
|
Rajesh Shrestha
“The termination of Mr. Shrestha’s employment is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
|
President, New Markets and Chief Business Officer | Terminated | 2022-03-25 |
| Yon Yoon Jorden | director | Appointed | 2021-12-27 |
| Jody Bilney | director | Appointed | 2021-12-27 |
Leadership
- John Kao CEO, Board Member
- Joseph Konowiecki Chairman
- James M. Head CFO
- Thomas Freeman CFO
- Sebastian Burzacchi COO
- Hakan Kardes CTO
- Robert L. Scavo CIO
- David Hodgson Board Member
- Jacqueline Kosecoff Board Member
- Jody Bilney Board Member
- Yon Yoon Jorden Board Member
Key facts
CIK
1832466
CUSIP
01625V104
13F (30d)
332 filings
312 filers
Visit website
Investor relations